Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Hospital Medicine (London, England : 1998)|June 30, 2004
Stroke medicine: a new subspecialtyIan StarkeClinical Toxicology (Philadelphia, Pa.)|October 31, 2019
Gadolinium-based contrast agents - what is the evidence for 'gadolinium deposition disease' and the use of chelation therapy?Kerry A Layne, David M Wood, Paul I DarganInvestigative Radiology|June 4, 2021
Gadolinium Concentrations in Biological Matrices From Patients Exposed to Gadolinium-Based Contrast AgentsKerry A Layne, Kishor Raja, Paul I Dargan, et al.Clinical Medicine (London, England)|May 16, 2008
Specialist recertification: a survey of Members and FellowsKirstyn Shaw, Mary Armitage, Ian StarkeBritish Journal of Clinical Pharmacology|July 23, 2018
Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agentsKerry A Layne, Paul I Dargan, John R H Archer, et al.Investigative Radiology|February 20, 2020
Establishing Reference Intervals for Gadolinium Concentrations in Blood, Plasma, and Urine in Individuals Not Previously Exposed to Gadolinium-Based Contrast AgentsKerry A Layne, David M Wood, Miriam Dixon-Zegeye, et al.Medical Teacher|July 27, 2010
'Effectiveness of Continuing Professional Development' project: a summary of findingsJill Schostak, Mike Davis, Jacky Hanson, et al.British Journal of Clinical Pharmacology|June 6, 2020
Acute toxicity related to misuse (nonmedical use) of tramadol: Experience of the European Drug Emergencies Network PlusKerry A Layne, Paul I Dargan, Alison M Dines, et al.Pageof 1